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Summary
Reasons for performing study: Alveolar macrophages (AMs) are the first line of defence against pathogens in the lungs of all mammalian species and
thus may constitute appropriate therapeutic target cells in the treatment and prevention of opportunistic airway infections. Therefore, acquiring a
better understanding of equine macrophage biology is of paramount importance in addressing this issue in relation to the horse.
Objectives: To compare the transcriptome of equine AMs with that of equine peritoneal macrophages (PMs) and to investigate the effect of
lipopolysaccharide (LPS) on equine AM.
Study design: Gene expression study of equine AMs.
Methods: Cells from both bronchoalveolar and peritoneal lavage fluid were isolated from systemically healthy horses that had been submitted to
euthanasia. Cells were cryopreserved. RNA was extracted and comparative microarray analyses were performed in AMs and PMs, and in AMs treated
and untreated with LPS. Comparisons with published data derived from human AM studies were made, with particular focus on LPS-induced
inflammatory status.
Results: The comparison between AMs and PMs revealed the differential basal expression of 451 genes. Gene expression analysis revealed an
alternative (M2) macrophage polarisation profile in AMs and a hybrid macrophage activation profile in PMs, a phenomenon potentially attributable to a
degree of induced endotoxin tolerance. The gene expression profile of equine AMs following LPS stimulation revealed significant changes in the
expression of 240 genes, including well-known upregulated inflammatory genes. This LPS-induced gene expression profile of equine AMs more closely
resembles that of human rather than murine macrophages.
Conclusions: This study improves current understanding of equine macrophage biology. These data suggest that the horse may represent a suitable
animal model for the study of human macrophage-associated lung inflammation and data derived from human macrophage studies may have significant
relevance to the horse.
Keywords: horse; lungs; peritoneal cavity; lipopolysaccharide; microarray
Introduction
The mucosal surface of the lung is continuously exposed to potential
pathogens, proinflammatory particulates and inhaled toxins. In addition to
the barriers provided by surfactants and mucus, alveolar macrophages
(AMs) provide a first line of immune defence and an efficient mechanism of
particulate and pathogen clearance. They also play a key role in the
initiation and propagation of both acute and chronic lung injury-induced
pathology [1]. The function and gene expression of AMs in other species
have proved to be distinct from those of macrophages derived from other
anatomic locations, reflecting both a unique environment and a distinct
pathway of differentiation [2,3]. Although we have previously identified and
reported various functional and phenotypic differences between equine
AMs and peritoneal macrophages (PMs) [4], to date no published data exist
on such a comparison in the horse at the level of cellular global gene
expression. We consider this to be a natural progression from the
previously identified differences between these cell populations.
Furthermore, recognition of the potential importance of endotoxin in
various equine airway diseases is evidenced by the publication of numerous
studies reporting the transcriptomic and protein translational response of
the equine AM to a lipopolysaccharide (LPS) stimulus [4,5]. However, such
reports have focused on the transcription and translation of specific genes
and inflammatory proteins. We therefore considered the generation of LPS-
induced global gene expression data in the equine AM to be justified as an
exercise which permits a more detailed comparison with the LPS response
of AMs derived from other species. Indeed, despite the likely critical
importance of AMs in equine airway defence, much of our presumed
knowledge of equine AM biology is extrapolated from data derived from
other species. Such translation of data derived from one species to another
assumes a degree of conservation of key biological processes; however,
this assumption is often unsubstantiated. For example, despite the common
use of murine model-derived data to improve our understanding of human
innate immunity, there is an ever-increasing appreciation that significant
differences exist between man and mice with respect to the gene
expression profiles associated with certain pathologies [6,7]. Therefore, an
appreciation of both similarities and dissimilarities between the equine AM
and AMs derived from other species is a necessary prerequisite to the
translation of data derived from other species to the horse, and vice versa.
To further characterise the specific biology of the equine AM, we
analysed the basal gene expression of equine AMs and made comparisons
with, firstly, the basal gene expression of an alternative macrophage
population (PMs) and, secondly, the LPS-induced gene expression of
equine AMs. Additionally, to further investigate the appropriateness of the
horse as an abundant source of cells for translational studies of human AM
biology, we compared data on the LPS-induced gene expression of equine
AMs with previously published data on LPS-induced AM gene expression
in both man and mice.
Materials and methods
Cell isolation
Bronchoalveolar and peritoneal lavage samples were obtained post-
mortem from 5 to 3 systemically healthy horses, respectively. The horses
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(7 female and one male; median age: 17 years [range: 4–20 years]) were
submitted to euthanasia at the Equine Hospital at the Royal (Dick) School of
Veterinary Studies, Edinburgh University, Edinburgh, UK) by the i.v.
administration of secobarbitone and cinchocaine (SomuloseTMa). The
reasons for euthanasia were predominantly related to orthopaedic or
behavioural issues. None of the horses were submitted to euthanasia as a
result of underlying intestinal or respiratory disease.
Cells from both bronchoalveolar and peritoneal lavage fluid were
isolated and cryopreserved as previously described [4]. Prior to
cryopreservation, an aliquot of lavage fluid was retained for cytological
analysis and differential cell count calculation, achieved by counting 500
cells under light microscopy [4,8]. Horses were considered free from
inflammatory airway disorders based on the respective differential cell
ratios not exceeding the following cut-off values: neutrophils, 10%; mast
cells, 5%, and eosinophils, 2% [9,10].
Cell culture
Thawed cells were seeded in duplicate (1 9 106 cells/mL) in Petri dishes in
complete medium: RPMI-1640 medium supplemented with GlutaMAXTM-I
Supplementb, penicillin/streptomycinb and 10% heat-inactivated horse
serum (HS) (cat. no. H1138c ) and incubated at 37°C and 5% carbon dioxide
overnight. The next day, nonadherent cells were removed and fresh
complete medium was added before adherent cells were stimulated with
LPS (100 ng/mL) from Salmonella enterica serotype Minnesota Re 595
(L9764)c. Supernatant from the plates was collected prior to and 6 h
following LPS stimulation.
RNA extraction
RNA was extracted from both AMs and PMs using 1 mL RNA-Beed. RNA
concentration and purity were measured using ND-1000 Nanodrope. RNA
integrity was also confirmed with the RNA 6000 Pico Assayf; an RNA
integrity value of >7 was considered appropriate for microarray.
Microarray assay
Microarrays (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSe69871)
were processed by Edinburgh Genomics (http://genomics.ed.ac.uk). The
libraries prepared from RNA samples (50 ng) were hybridised to Equine
Gene 1.1 or to 1.0 ST Array Strips from Affymetrixg, according to the
manufacturer’s instructions. The same group of 30,559 probesets was
used in both array types. The Affymetrix analysis procedure is a single-
dye protocol, which thereby avoids problems of dye bias. Image
preparation and the CEL files required for analysis were produced using
Affymetrix Gene Chip Command Console Version 3.0.1g. Expression
values were normalised according to the RMA algorithm [11]. The
Equine Gene 1.1 ST Array Strip was used for basal and LPS-induced AM
gene expression analyses in 3 horses. Thereafter, all subsequent
analyses (AMs and PMs) were conducted using 1.0 ST Array Strips. CEL
files were imported to Partek Genomic Suite 6.6h for the microarray data
analysis, using default parameters. The human microarray datasets used
for comparison were derived from a human study [12] (GDS4419;
platform: GPL570 [HG-U133_Plus_2]; Affymetrix Human Genome U133
Plus 2.0 Arrayg) and were submitted to the same analysis. Consistent
with cut-off values widely used in microarray data analysis, changes of
at least 2-fold in magnitude and a P value of 0.05 were applied in all
experiments with the exception of comparisons between AMs and PMs,
in which the extensive gene list generated was considered to justify the
use of more rigorous cut-off points (a 9-fold change and a P value of
0.01). In the first analysis, 5 untreated AMs were compared with 3
untreated PMs, whereas in the second analysis, 5 untreated AMs were
compared with 5 LPS-treated AMs.
A network analysis of expression data was performed in BioLayout
Express3D [13], whereby pairwise Pearson correlation coefficients (r) were
calculated and a threshold of r ≥ 0.93 was chosen for the transcript-to-
transcript comparison across array samples. The resulting network graph
consists of nodes (representing transcripts) and edges, representing
correlations above the threshold between the expression patterns of the
transcripts. The Markov cluster algorithm (MCL) was used with an inflation
value of 2.2 [13] to identify groups of tightly coexpressed genes. Clusters
are numbered according to the number of transcripts they contain: Cluster
1 has the greatest number of transcripts. Transcripts with a dynamic range
of <1.5 were removed from the analysis. Only clusters that showed
consistent up- or downregulation of genes across all samples in the group
were analysed; any clusters resulting from aberrant expression in a single
horse were excluded.
Functional annotation
Initial annotation used the most recent Affymetrix annotation file imported
into the Partek softwareh or identified in the Affymetrix Netaffx siteg (http://
www.affymetrix.com). Partek Genomic Suite Version 6.6h was used to
determine the biological processes of the genes included in the gene lists.
Results
Cell recovery and populations
Approximately 3 9 108 AMs and 2 9 108 PMs were isolated from each of
the 8 horses. Differential cell counts of bronchoalveolar lavage fluid
showed a mean  s.d. of 69.7  7.2% macrophages, 22.0  9.0%
lymphocytes, 3.5  5.0% neutrophils and 4.8  3.0% mast cells. In the
peritoneal lavage fluid, a mixed population of 43.7  13.1% macrophages,
10.3  7.6% lymphocytes and 46.0  19.1% neutrophils was identified.
Following overnight culture, nonadherent cells were removed. More than
85% of adherent cells, from both alveolar and peritoneal lavages, were
identified morphologically as macrophages after the culture plates had
been submitted to Leishman staining. Cell viability on the day of cell
harvesting exceeded 90% as assessed by Trypan blue staining.
Gene expression in equine AMs and PMs
Figure 1(a) shows a principal component analysis (PCA) of the combined
AM and PM gene expression results. A statistically significant difference in
the expression of 451 (P<0.01, >9-fold change) transcripts was identified
between AMs and PMs; however, few had informative annotation
(Supplementary Item 1). A more extensive gene list with less stringent cut-
off levels (P<0.05 and >2-fold change) was also created (Supplementary
Item 1). As an alternative approach, the same normalised data were
analysed using BioLayout Express3D software, with an MCL inflation value
of 2.2, a Pearson correlation coefficient threshold of 0.93 and the smallest
cluster set at 3 nodes. The graph created consisted of a total of 12,341
nodes, connected with 1,947,031 edges. This provided a more in-depth
understanding of the gene expression profiles of the 2 cell types.
Consistent with the results of the PCA, network analysis (Fig 1b) clearly
distinguished 2 groups of clusters, of which one consisted of genes with
higher expression in AMs and one consisted of genes with higher
expression in PMs. The top clusters of transcripts with comparatively
greater expression in AMs were numbers 2, 3, 4 and 5; those in PMs were
numbers 1, 8, 15, 17 and 25. Total gene lists of these clusters of AMs and
PMs are presented in Supplementary Item 1.
Analysis of AM gene expression suggested an important role of cellular
metabolic processes, myeloid cell differentiation and immune response. In
particular, the genes more highly expressed in AMs included genes
specifically expressed by macrophages or encoding proteins highly
involved in macrophage differentiation, such as CSF1 and its receptor. Of
transcripts showing relatively greater expression in AMs, many were
clearly related to immune response. These included genes such as
Mannose receptor C type 1 (MRC1), genes that play a role in the nuclear
factor jB (NFjB) signalling pathway, the transforming growth factor-b1
gene (TGFB1), several pattern recognition receptors (TLR6, TLR7, TLR8),
members of the tumour necrosis factor (TNF) and TNF receptor
superfamily, and interleukin IL18 and interleukin receptors (IL6R, IL17R). In
PMs, the genes most highly expressed (in particular the Cluster 1
expression profile) were associated with inflammatory defence and
immune response. Examples of these included several chemotactic
chemokines (CXCL1, CXCL3, CXCL6), and both pro- and anti-inflammatory
cytokines (IL1A, IL1B, IL6, IL8, IL10). The full list is presented in
Supplementary Item 1.
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LPS-induced gene expression in equine AMs
All of the LPS-stimulated AMs showed an increase in TNFa secretion, as
reported previously [4]. LPS treatment of the AMs produced a radical
change in gene expression, and the PCA of the resulting data clearly
separated the baseline and LPS-treated datasets (Fig 2a). The expression
of 240 genes was significantly altered by LPS stimulation (P<0.05,
>2-fold change); 220 of these were upregulated and 20 were
downregulated. By contrast with the set of genes differentially
expressed between AMs and PMs, the LPS-regulated AM-derived genes
were predominantly well annotated and previously identified in other
species (Supplementary Item 2). The main gene functional groups
induced by LPS are presented in Fig 2(c, d). In order to characterise
these genes, the enrichment score of biological processes in the genes
upregulated by LPS stimulation was calculated (Fig 2c). The second most
important gene functional group induced by LPS includes all immune
system processes. A deeper analysis (Fig 2d) revealed biological
processes involved in this immune response such as leucocyte migration
or activation.
The top 30 upregulated genes include well-known inflammatory
genes such as TNF, PTX3, signal transducer and activator of
transcription protein 4 (STAT4), IL6 and indoleamine 2,3-dioxygenase 1
(IDO1), guanylate binding protein 5 (GBP5) (Fig 2b). The LPS-induced
expression of many genes related to apoptosis and programmed cell
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Fig 1: Alveolar macrophages (AMs) and peritoneal macrophages (PMs) display different gene expression profiles at homeostasis. (a) Principal component analysis was
conducted in 5 samples of AMs and 3 samples of PMs. (b) Network analysis of genes differentially expressed in AMs and PMs at homeostasis. The graph was generated
by BioLayout Express3D software (MCL 2.2, r ≥ 0.93). Nodes with the same colour belong to the same cluster of coexpressed genes. The graphs at the right show
expression profiles of genes expressed more highly in AMs and PMs, respectively. The x-axis shows each horse and the y-axis shows the normalised relative intensity of
expression in that horse.
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death detected in the current study was consistent with the well-
established phenomenon of constant interaction between inflammation
and apoptosis, such as apoptotic peptidase activating factor 1 and
caspase 7 [14]. Numerous transcription factors, such as STAT4, ETV7
and basic leucine zipper transcriptional factor ATF-like 3 (BATF3) were
also found. A large number of genes responsible for the initiation and
maintenance of inflammation were detected; examples included
members of the TNF and TNF receptor superfamily (TNF, CD40,
TNFSF13B), interleukins (IL1a, IL1b, IL2Ra, IL6, IL27) and
chemoattractant chemokines (CCL2, CXCL3, CXCL6). The inducible gene
list also included several secreted growth factors, including Schlafen
family member 5 and CSF3 (Supplementary Item 2). Network analysis
using BioLayout Express3D confirmed the results shown here (data not
shown).
LPS response in horse macrophages is similar to that
in human macrophages
Data for the equine LPS-induced genes were compared with published
data for human AMs (GDS4419) [12]. Analysis revealed 66 orthologous
genes induced in both species (Fig 3a). Many of these were shared with
equine AMs, including STAT4, IDO1 and BATF3 (Fig 3b). IDO1 and NOS2
(nitric oxide synthase 2) are 2 genes that perfectly depict the differences
between mice and man [15]. Equine AMs and PMs, like human and porcine
macrophages, did not metabolise arginine to produce nitric oxide (NO) as
do mouse macrophages. Rather, human and porcine macrophages
metabolise tryptophan through the induction of indoleamine dioxygenase
(encoded by the IDO gene) [16,17]. Figure 3(c) shows the expression
patterns of these genes in horse and human AMs. IDO1 was upregulated
after LPS stimulation in the horse, although to a lesser extent, whereas
basal NOS2 expression did not differ from that detected in LPS-stimulated
cells.
Discussion
These data confirm that AMs in the horse, like those in other species, have
a unique gene expression profile. The greater AM expression of genes
related to macrophage differentiation and development, such as CD14,
CD68, CD71 and CD163 [12,18] complemented our previous results derived
from flow cytometric analysis, which confirmed the cell surface expression
of most of these markers [4]. Some of the genes more highly expressed in
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Fig 2: Lipopolysaccharide (LPS)-induced gene expression in equine alveolar macrophages (AMs). (a) Principal component analysis indicates differences in gene expression
profiles between LPS-treated and untreated cells. Analysis was performed using Partek Genomic Suite Version 6.6.h This is a 3D presentation of the microarray
expression data. The relative difference in colour intensity for each group reflects the transcription of a 3D image onto a 2D format. (b) Top upregulated genes in AMs
after 6 h of LPS stimulation. Genes are sorted in order of their fold change increase. (c) Main gene functional groups induced by LPS treatment in horse AMs. The gene
ontology analysis tool from the Partek Genomic Suiteh was used. The histogram shows the main gene functional groups affected by LPS stimulation. (d) The immune-
related biological processes in which the upregulated genes are involved.
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AMs have previously been shown to have lung-specific roles; these include
CS2RB, which is shown in man to regulate surfactant homeostasis [19].
Furthermore, the greater expression in AMs of several members of the
scavenger receptor family, C-type lectins and others (CD14, CD40, CD68,
CD163, MRS1) essential for functions such as endocytosis, phagocytosis,
adhesion and antigen recognition [20], was also consistent with our
previous finding that AMs showed a greater capacity for phagocytosis
compared with PMs [4]. Moreover, analysis of pig macrophages [21,22]
revealed that AMs specifically over-express many C-type lectins compared
with other tissue macrophage populations, an adaptation that may support
the recognition of inhaled particles. Equine AMs also showed relatively
greater expression of certain important pattern recognition receptors,
findings which are likely to reflect the airway’s status as a common site of
airborne viral and bacterial challenge.
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The greater expression of genes encoding TGFB1, which plays a key role
in alveolar homeostasis [23], and the C-type lectin MRC1, which is also
highly expressed in porcine AMs [21,22], is supportive of a predominantly
M2 (alternatively activated) phenotype in equine AMs, which may play a
role in suppressing spontaneous and/or over-exuberant inflammation in the
lung [24]. By contrast, the highly expressed transcripts identified in PMs
may reflect either a classical [M1] (CXCL1, CXCL3, IL1A, IL1B, IL8, NFKB2) or
an alternative [M2] (CCL22, IL4R, IL10) phenotype. Although a more
activated state in PMs might be supported by the greater expression of the
acute phase protein PTX3 and several interferons (IFNA1, IFNA2), certain
PM transcripts (IFNA2, IL6) are more supportive of a novel state of hybrid
polarisation recently reported in murine LPS-tolerant macrophages [25].
Both of these features may partly explain the previously reported
nonresponsiveness of horse PMs to an LPS stimulus [4]. Additionally, the
PM expression of several neutrophil chemoattractants is consistent with
neutrophil presence within the peritoneal fluid of healthy horses. It is
possible that both the presence of neutrophils within, and the LPS
tolerance of macrophages derived from, the peritoneal cavity of horses
may reflect low-grade endotoxin translocation across the gastrointestinal
tract. Furthermore, the PM expression of certain hypoxia-induced genes
(VEGFA, FLT1, CXCR7, HIF3A) may reflect the hypoxic environment of the
peritoneal cavity [26,27].
The sizes of samples of AMs and PMs were relatively small and samples
came from different horses, which is a limitation of this study. However,
the use of BioLayout Express3D allowed us to identify and exclude any
genes that were up- or downregulated in a single sample (single animal)
and hence the genes in our analysis are those that were consistently
differentially regulated. The fact that the changes seen are largely
corroborated by studies in other species indicates that this analysis is
robust despite the small sample size.
Although the LPS response of equine AMs has been subject to
previous study by others, largely justified by the hypothesised role of
inhaled endotoxin in certain equine environmental airway diseases [5,28],
the data presented here are the most comprehensive to date. LPS-
induced upregulation of many of the genes identified has previously
been reported in a variety of species, including the horse [28,29]. In
comparison with equine monocytes, in which LPS seems to activate
mainly targets of the MyD88 pathway [30], our data revealed LPS-
induced activation of both MyD88 (TNF, IL1, IL6, IL10) and TRIF (IFNB,
CCL5) pathways in equine AMs, a finding which may reflect a degree of
adaptation to the unique airway microenvironment. Similarly, the
detection of anti-inflammatory genes and genes related to both
apoptosis and cytoprotection (IL1RN, SOCS3) [31] may reflect a role for
AMs in minimising collateral tissue damage in a delicate tissue
environment adapted for efficient gas exchange yet variably exposed to
proinflammatory agents on a breath-by-breath basis. The greater LPS
responsiveness and phagocytic capacity of AMs compared with PMs
and the negligible neutrophil presence within this compartment probably
reflect their adaptation to this key role. Furthermore, the transcriptomic
data generated in this study provide a valuable reference dataset
against which the biological effects of various novel therapeutic and/or
prophylactic interventions aimed at up- or downregulating the innate
immune response might be measured.
Comparison of our LPS-induced gene expression data with those
derived from studies in human AMs revealed many similarities [6,12]. A
total of 66 orthologue genes amongst the differentially expressed genes
were identified, 63 of which followed similar patterns of expression
across species. As well as including genes involved with the stereotypical
immune response to bacteria, this list included genes that were induced
in man but not in mice. It would therefore appear that a dissimilarity in
LPS-induced macrophage gene expression also exists between the horse
and the mouse, similar to that previously reported following man and
mouse, and pig and mouse macrophage comparisons [6,15]. The failure
to detect the LPS-induced expression of genes involved in the NO
pathway is consistent both with our previous inability to detect LPS-
induced NO metabolism in equine AMs [4] and with gene expression
data derived from both human and porcine studies [15,32]. By contrast
with murine macrophages, man- and pig-derived macrophages in vitro
metabolise tryptophan via IDO (indoleamine-pyrrole 2,3-dioxygenase)
rather than producing NO via arginine metabolism in response to LPS
[6,15]. Similarly, and in agreement with previous reports derived from
equine AMs [4,33], our data also provide evidence of tryptophan
metabolism with the subsequent upregulation of IDO in the horse, thus
further supporting a common pathway in this species and in both the
pig and man. In light of the previously reported fundamental differences
in human and murine cellular biology and the associated requirement for
the development of novel animal models [15,34], the similarities between
man and horse macrophage gene expression revealed by our study
justify further evaluation of the horse as an appropriate model for human
subject inflammatory research and offer more assurance of the
appropriateness of extrapolating from human subject-derived data in this
field of study.
Conclusions
In combination, the findings described in this study have significantly
increased our knowledge of equine macrophage biology, particularly that
of AMs. Tissue-dependent heterogeneity of macrophage function and
phenotype was demonstrated and represents an appropriate platform of
knowledge on which future studies can be based. The interspecies
comparative data provide support for the potential role of the horse as a
model for studies on human macrophage biology and completion of the
equine genome annotation would provide a major tool for future
transcriptomic horse studies, the findings of which may also be applicable
in man.
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